Type 1 Diabetes Mellitus clinical trials

Explore recruiting type 1 diabetes mellitus clinical trials.

Recruiting type 1 diabetes mellitus studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Type 1 Diabetes Mellitus trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A GLP-1 receptor PET imaging add-on study within the VERA-T1D trial investigating the effects on beta cell mass (Image-VER-A-T1D)

Austria, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Prevention of CKD progression in type 1 diabetes with Long term Use of SGLTi avoiding kidney hypOxia (PLUTO)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

INfluenza VaccInation To mitigate typE 1 Diabetes (INVITED trial)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-264 in Subjects With Type 1 Diabetes Mellitus

Netherlands, Germany, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3938577 in Healthy Participants and Participants with Type 1 Diabetes Mellitus.

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Diamyd® to Preserve Endogenous Beta Cell Function in Adolescents and Adults with Recently Diagnosed Type 1 Diabetes, Carrying the Genetic HLA DR3-DQ2 Haplotype

Germany, Spain, Czechia, Netherlands, Hungary, Estonia +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Type 1 Diabetes Mellitus trials by city

Type 1 Diabetes Mellitus in Toronto Type 1 Diabetes Mellitus in Vancouver Type 1 Diabetes Mellitus in Montreal Type 1 Diabetes Mellitus in Calgary Type 1 Diabetes Mellitus in Edmonton Type 1 Diabetes Mellitus in Ottawa Type 1 Diabetes Mellitus in Winnipeg Type 1 Diabetes Mellitus in Quebec City Type 1 Diabetes Mellitus in Hamilton Type 1 Diabetes Mellitus in Kitchener Type 1 Diabetes Mellitus in London Type 1 Diabetes Mellitus in Halifax Type 1 Diabetes Mellitus in New York Type 1 Diabetes Mellitus in Los Angeles Type 1 Diabetes Mellitus in Chicago Type 1 Diabetes Mellitus in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease